Stay updated with breaking news from India Formulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sun Pharma said revenue for the quarter jumped 14.27 per cent YoY to Rs 10,725.57 crore compared with Rs 9,386.08 crore in teh corresponding quarter last year. The revenue growth was in line with analyst projections.
Spain headquartered Chemo Pharma, on the first day of the World Economic Forum, announced an investment of over Rs 100 crore in the creation of the second line
Spain headquartered Chemo Pharma, on the first day of the World Economic Forum, announced an investment of over Rs 100 crore in the creation of the second line in their production area in Hyderabad for the production of pharmaceutical finished dosage forms.
The acquisition will strengthen Lupin’s India Formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products